Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intrathecal use. It provides enhanced radiographic contrast for diagnostic imaging procedures in patients undergoing angiography, arthrography, myelography, computed tomography and other contrast‑enhanced studies.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution through established regulatory frameworks.

Iopamiro, an iodinated contrast agent, is used to enhance radiographic visualization in several diagnostic procedures.

- Angiography: improves vessel delineation for accurate assessment of arterial and venous structures. - Arthrography: provides joint space contrast to evaluate cartilage, ligaments and menisci. - Myelography: enhances spinal canal imaging to detect nerve root compression or lesions. - Computed Tomography (CT) imaging: increases tissue contrast for detailed cross‑sectional visualization. - Contrast‑enhanced radiographic procedures: facilitates detection of lesions, tumors and vascular abnormalities.

Iopamiro may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Nausea or mild vomiting. - Headache or mild dizziness.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Hypotension or cardiovascular collapse. - Pulmonary edema or respiratory distress.

Prior to using Iopamiro, several precautionary measures should be observed to ensure patient safety.

- Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: identify prior reactions to iodinated contrast or iodine‑containing substances. - Ensure adequate hydration: maintain fluid balance to reduce risk of contrast‑induced nephropathy. - Avoid use in patients with known severe iodine allergy: consider alternative imaging methods. - Monitor vital signs: observe blood pressure, heart rate and oxygen saturation during and after injection. - Store at ambient temperature: keep the vial in original packaging, protect from light and moisture.

Iopamiro can interact with certain medications, affecting safety or efficacy.

Major Interactions (Avoid): - Nephrotoxic drugs: aminoglycosides, loop diuretics and NSAIDs may increase risk of renal injury. - Radioactive iodine therapy: concurrent use can interfere with iodine handling and imaging results. - Metformin in patients with renal impairment: risk of lactic acidosis; consider temporary discontinuation.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask signs of contrast‑induced hypertension. - ACE inhibitors or ARBs: can potentiate renal effects of contrast media. - Diuretics: affect intravascular volume status, requiring careful monitoring.